Global Coalition on Aging Calls for Adult Immunization to Top the Global Policy Agenda as a Core Preventive Health Strategy

New Report Shows Effectiveness of Immunization Through All Life Stages

NEW YORK CITY (July 11, 2013) – The Global Coalition on Aging (GCOA) today called for attention from policymakers and the global health community to adopt a life-course approach to immunization.  In its new report, “Life-Course Immunization: A Driver of Healthy Aging,” GCOA highlights the absence of adult immunization in healthy aging strategies and the need for a greater awareness of the role of vaccines as a preventive measure as the global population ages.

The report was authored by a panel of experts across the medical fields of infectious disease and epidemiology, as well as global health policy and advocacy.  Authors include Javier Garau, Associate Professor of Medicine at the University of Barcelona and chair of SAATI (Supporting Active Ageing Through Immunisation); Michael W. Hodin, PhD, Executive Director of the Global Coalition on Aging; and Alexandre Kalache, MD, PhD, President of the International Longevity Centre – Brazil.

The global over-60 population will more than double between 2000 and 2050, reaching 2 billion, while the under-14 population contracts.  With this population structure shift comes the need for actionable aging strategies to address the ensuing health, social and economic challenges that accompany longevity.  A general assumption is that the aging process is marked by disability and dependence, and in fact, as one ages, the immune system gradually deteriorates, thus increasing the risk of vaccine-preventable diseases.  However, medical innovations that prevent disease and therefore lead to healthier and more active aging – and cost savings – do exist.  These tools unfortunately have been underutilized.

Although immunization has become a staple in the development and health care of today’s children, systematic immunization for adults has not.  GCOA urges policymakers to learn from the success of the GAVI Alliance, which in one decade reached 257 million children with new and underused vaccines, thus preventing 5 million future deaths.  This success is commendable, and yet older adults are at the greatest risk for diseases which are preventable by vaccine.

“Longevity is a gift of 20th-century progress in health, sanitation and medical innovation, and it is essential in the 21st century that we take action and adapt to a population structure the world has never before seen,” said Hodin.  “Immunization has been a proven preventive strategy in children.  Now, with the aging shift, it has become a social and economic imperative for public health strategies to include a life-course approach to immunization.  It is also common sense that we would apply the valuable lessons from childhood immunization campaigns to today’s aging population.”

A life-course approach to immunization stresses vaccination through all stages of life, including the adult years, as a cost-effective strategy to promote healthy aging.  According to the GCOA report, one study “found that influenza immunization and pneumococcal immunization rank among the best preventive health services, as highly as smoking cessation and cancer screening.”  Further, “immunization throughout the life-course enables adults to age with reduced risk to disease, thereby enabling healthier, more active, and more productive aging.” This approach requires increased awareness and action to place adult vaccination at the top of the global public health agenda.  Currently, adult vaccination rates persist at far below target levels.

“As the population ages, we have an opportunity and a responsibility to ensure that longer life is marked by maintaining independence and preventing disability and illness,” said Garau.  “Many diseases which impact older adults are preventable, and a life-course approach to immunization is a powerful tool for enabling individuals and strengthening societies to be healthier and more productive.”

According to “Life-Course Immunization: A Driver of Healthy Aging,” there are six key policy areas upon which improvement can be made to further goals of improving quality of life while one ages.

  1. Increase awareness regarding the health benefits of life-course immunization among healthcare professionals, employers, employee groups, and unions.
  2. Establish or enhance existing surveillance systems to determine and monitor the burden of vaccine-preventable diseases in adults.
  3. Create alignment on adult vaccination schedules.
  4. Integrate adult immunizations into Electronic Medical Records (EMRs) and create an adult immunization registry.
  5. Integrate adult vaccination in public and private payer access programs.
  6. Embed adult vaccination in core preventive services for adults.

The report was supported through a sponsorship from Pfizer Inc.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.

Menopause, the Silver Economy and Workplace Opportunities

As we recognise World Menopause Day, take a moment to consider the economic power, diverse expertise and skills, and incredible societal contributions of the estimated 1.1 billion post-menopausal women worldwide by 2025—a population on-par with China or India, and dwarfing any other country. Indeed, if we want to fuel the vibrant $15 trillion silver economy, societies, governments, and employers must empower older women in the future of work, including solutions that fight stigma and increase workplace support related to menopause.

Best Practices for Engaging a Multigenerational Workforce

Employers are grappling with a myriad of workforce-related issues ranging from productivity to attracting and retaining talent, but many may be overlooking some seismic shifts that are reshaping the future of work: longevity, population aging, and the multigenerational workforce.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.